(Q43716531)

26 November 2017

title

Cyclic pamidronate therapy in children with osteogenesis imperfecta: results of treatment and follow-up after discontinuation (English)

1 reference

26 November 2017

main subject

osteogenesis imperfecta

0 references

author name string

Nesibe Andiran

1

1 reference

26 November 2017

Ayfer Alikasifoglu

2

1 reference

26 November 2017

Nazhl Gonc

3

1 reference

26 November 2017

Alev Ozon

4

1 reference

26 November 2017

Nurgun Kandemir

5

1 reference

26 November 2017

Nursen Yordam

6

1 reference

26 November 2017

language of work or name

1 reference

1 January 2008

1 reference

Journal of Pediatric Endocrinology and Metabolism

26 November 2017

published in

1 reference

26 November 2017

volume

21

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

63-72

1 reference

Genetic heterogeneity in osteogenesis imperfecta

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Lack of effects of human calcitonin in osteogenesis imperfecta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Therapy of osteogenesis imperfecta with synthetic salmon calcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Bisphosphonates: from grandparents to grandchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Pamidronate treatment of osteogenesis imperfecta--lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Rapid Increase in Grip Force After Start of Pamidronate Therapy in Children and Adolescents With Severe Osteogenesis Imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Benefits of pamidronate in children with osteogenesis imperfecta: an open prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Osteogenesis imperfecta: anthropometric, skeletal and mineral metabolic effects of long-term intravenous pamidronate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Intravenous pamidronate treatment in children with moderate to severe osteogenesis imperfecta: assessment of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Pamidronate in children with osteogenesis imperfecta: histomorphometric effects of long-term therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Pamidronate treatment of less severe forms of osteogenesis imperfecta in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

Early bisphosphonate treatment in infants with severe osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.1.63

10.1515/JPEM.2008.21.1.63

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference